logo-loader
RNS
viewReckitt Benckiser

Directorate Change

/**/ h1{margin:0cm;margin-bottom:.0001pt;font-size:24.0pt;font-family:"Times New Roman","serif";font-weight:bold;}h2{margin:0cm;margin-bottom:.0001pt;font-size:15.5pt;font-family:"Times New Roman","serif";color:#2461AA;font-weight:bold;}p{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: purple } .af{size:595.3pt 841.9pt;margin:39.7pt 89.85pt 65.2pt 89.85pt;}div.af{}p.ap{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Arial","sans-serif";text-align: center}span.an{font-size:10.0pt}p.aq{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Arial","sans-serif";font-weight: bold}p.ar{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Arial","sans-serif";font-weight: bold; text-align: center}span.ak{font-size:14.0pt}p.a,li.a,div.a{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Arial","sans-serif";}p.as{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Arial","sans-serif";text-align:justify}p.at{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Arial","sans-serif";font-weight: bold; text-align: justify} p.au{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Arial","sans-serif";margin-top:11.0pt;margin-right:0cm;margin-bottom: 11.0pt;margin-left:0cm} /**/
RNS Number : 8884G
Reckitt Benckiser Group PLC
29 July 2019
 

                                                                                                            29 July 2019

 

 

DIRECTORATE CHANGE:

Mary Harris: Appointment as designated Non-Executive Director

 

 

Reckitt Benckiser Group plc is pleased to announce the appointment of Mary Harris, as designated Non-Executive Director, for engagement with the Company's workforce, in line with the provisions of the UK Corporate Governance Code 2018 (the "Code"), with effect from 26 July 2019.

 

Mary joined the Board in February 2015 and currently sits on the Nomination and Remuneration Committees, chairing the latter.

 

There are no additional details relating to the appointments that are required to be disclosed pursuant to Listing Rule 9.6.11(3).

 

 

 

For further Information:
Rupert Bondy

Company Secretary

Tel +44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations

Tel. +44 (0)1753 217 800

 

 

About RB:

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. 

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. 

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide. 

For more information visit www.rb.com

 *RB is the trading name of the Reckitt Benckiser group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOAPGUPWMUPBGUQ

Quick facts: Reckitt Benckiser

Price: 5841

Market: LSE
Market Cap: £41.44 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS

Total Voting Rights

2 weeks, 3 days ago

Director/PDMR Shareholding

2 weeks, 6 days ago

Director/PDMR Shareholding

3 weeks, 4 days ago

Q3 2019 Trading Update

3 weeks, 6 days ago

Directorate Change

4 weeks ago

Total Voting Rights

on 1/10/19